Medication info
Sildapamil Extended Release Tablets 5/50/750 mg

Sildapamil Extended Release Tablets 5/50/750 mg

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Phosphate Hydrate›64.3mg / 1 tabletDapagliflozin Propanediol Hydrate›6.2mg / 1 tabletMetformin Hydrochloride›750mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
Pale yellow oval-shaped extended release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202301625 · Approved 2023.05.22 · Insurance code 643508700

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine for antidiabetic therapy is 10mg of dapagliflozin and 100mg of sitagliptin; the dose of extended-release metformin hydrochloride should be determined based on each patient's current treatment regimen, efficacy, and tolerability, and should not exceed 2000mg. To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, take this medicine with food once daily, preferably in the evening. If the dose of metformin hydrochloride needs adjustment, adjust it gradually. Patients taking this medicine as the 5/50/500mg, 5/50/750mg, or 5/50/1000mg extended-release tablet should take 2 tablets once daily. Patients who do not achieve adequate glycemic control with combination therapy of metformin hydrochloride and sitagliptin should start this medicine at dapagliflozin 10mg, sitagliptin 100mg, and the current dose of metformin hydrochloride or a therapeutically similar dose. For patients switching to this medicine from combination therapy with dapagliflozin, sitagliptin, and metformin hydrochloride, the dose of this medicine should correspond to the previous doses of each component. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another glucose-lowering agent. Since changes may cause changes in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, this medicine must be swallowed whole and must not be split, crushed, ground, or chewed. This medicine may not dissolve completely and may be excreted in the stool. It is unknown whether the material excreted in the stool contains the active ingredients of the medicine. If a patient repeatedly reports finding this medicine in the stool, healthcare professionals should assess whether blood glucose is being adequately controlled (see Precautions for Use, 5. General Precautions). Special populations Patients with renal impairment The efficacy and safety of this medicine depend on renal function, and dosage adjustment according to renal function is required. Therefore, renal function should be assessed before and periodically after administration of this medicine. No dosage adjustment is necessary in patients with mild renal impairment. In patients with eGFR of 45mL/min/1.73m2 or higher and below 60mL/min/1.73m2, this medicine may be used by adjusting the dose of metformin hydrochloride, one of its components, provided it is well tolerated and the patient has no other condition that may increase the risk of lactic acidosis. The starting dose of extended-release metformin hydrochloride is 500mg or 750mg once daily; therefore, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000mg. If eGFR falls below 45mL/min/1.73m2, administration of this medicine should be discontinued immediately. Renal function should be assessed every 3~6 months.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to assist in blood glucose control for patients with type 2 diabetes. It is particularly effective when used in combination with dapagliflozin, sitagliptin, and metformin, and better results can be expected when combined with dietary and exercise therapy. This medication helps to manage blood glucose levels stably, aiding in the treatment of diabetes.

How to take

Adult dose

The recommended dose of this medicine for antidiabetic therapy is 10mg of dapagliflozin and 100mg of sitagliptin; the dose of extended-release metformin hydrochloride should be determined based on each patient's current treatment regimen, efficacy, and tolerability, and should not exceed 2000mg. To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, take this medicine with food once daily, preferably in the evening. If the dose of metformin hydrochloride needs adjustment, adjust it gradually. Patients taking this medicine as the 5/50/500mg, 5/50/750mg, or 5/50/1000mg extended-release tablet should take 2 tablets once daily. Patients who do not achieve adequate glycemic control with combination therapy of metformin hydrochloride and sitagliptin should start this medicine at dapagliflozin 10mg, sitagliptin 100mg, and the current dose of metformin hydrochloride or a therapeutically similar dose. For patients switching to this medicine from combination therapy with dapagliflozin, sitagliptin, and metformin hydrochloride, the dose of this medicine should correspond to the previous doses of each component. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from another glucose-lowering agent. Since changes may cause changes in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under careful monitoring. To maintain its extended-release properties, this medicine must be swallowed whole and must not be split, crushed, ground, or chewed. This medicine may not dissolve completely and may be excreted in the stool. It is unknown whether the material excreted in the stool contains the active ingredients of the medicine. If a patient repeatedly reports finding this medicine in the stool, healthcare professionals should assess whether blood glucose is being adequately controlled (see Precautions for Use, 5. General Precautions). Special populations Patients with renal impairment The efficacy and safety of this medicine depend on renal function, and dosage adjustment according to renal function is required. Therefore, renal function should be assessed before and periodically after administration of this medicine. No dosage adjustment is necessary in patients with mild renal impairment. In patients with eGFR of 45mL/min/1.73m2 or higher and below 60mL/min/1.73m2, this medicine may be used by adjusting the dose of metformin hydrochloride, one of its components, provided it is well tolerated and the patient has no other condition that may increase the risk of lactic acidosis. The starting dose of extended-release metformin hydrochloride is 500mg or 750mg once daily; therefore, treatment should not be initiated with this medicine. The maximum daily dose of metformin hydrochloride is 1000mg. If eGFR falls below 45mL/min/1.73m2, administration of this medicine should be discontinued immediately. Renal function should be assessed every 3~6 months.

Precautions

This medication contains sitagliptin, dapagliflozin, and metformin, which are used for the treatment of diabetes. First, the sitagliptin component can rarely cause serious allergic reactions, so if sudden rashes, difficulty breathing, or swelling of the face or neck occur after taking the medication, discontinue use immediately and seek medical care. Additionally, acute pancreatitis, which is inflammation of the pancreas, can occur, so if symptoms like abdominal pain, vomiting, or nausea arise, it is important to visit a hospital promptly. Next, the dapagliflozin component can reduce body fluid volume, potentially lowering blood pressure, thus caution is necessary for patients at risk of dehydration or hypotension. There is an increased risk of genital and urinary tract infections, so prompt treatment is necessary if any symptoms of infection are present. Also, very rarely, serious perineal necrosis, which is damage to skin and tissues, may occur; therefore, if pain, swelling, or redness appears around the genital area, consult medical personnel immediately. The metformin component can very rarely cause lactic acidosis, a serious metabolic disturbance; thus, if symptoms such as severe fatigue, difficulty breathing, or abdominal pain arise, immediate treatment is necessary. Patients with poor liver function or decreased kidney function should limit the use of this medication and undergo regular kidney and liver function tests. Additionally, there is a risk of hypoglycemia, so blood glucose changes should be monitored carefully if meals are skipped or irregular, if vigorous exercise is performed, or if insulin or other diabetes medications are used concurrently. This medication should not be administered to patients who are pregnant or have severe infections, heart failure, or acute myocardial infarction. While taking this medication, it is important to closely observe any changes in health status and to consult a doctor immediately if abnormal symptoms occur.

Side effects

  • Severe allergic reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hemorrhagic pancreatitis
  • necrotizing pancreatitis
  • lactic acidosis
  • hypoglycemia
  • genital infections
Show 227 more
  • vulvovaginitis
  • balanitis
  • fungal infections
  • perineal necrosis
  • decreased fluid volume
  • polydipsia
  • diabetic ketoacidosis
  • dizziness
  • constipation
  • dry mouth
  • back pain
  • dysuria
  • polyuria
  • nocturia
  • interstitial nephritis
  • increased hematocrit
  • decreased creatinine clearance
  • dyslipidemia
  • increased serum creatinine
  • increased blood urea
  • weight loss
  • urinary tract infections
  • cystitis
  • Escherichia coli urinary tract infection
  • genitourinary infections
  • pyelonephritis
  • bladder triangle inflammation
  • urethritis
  • kidney infection
  • prostatitis
  • rash
  • generalized rash
  • pruritic rash
  • macular rash
  • papular rash
  • pustular rash
  • vesicular rash
  • erythematous rash
  • myasthenia
  • pain
  • ligament sprain
  • keratitis
  • chronic obstructive pulmonary disease
  • hemoptysis
  • cerebral hemorrhage
  • peripheral artery occlusion
  • angina
  • myocardial infarction
  • choledocholithiasis
  • cholangitis
  • alcoholic liver cirrhosis
  • depression
  • suicide attempt
  • gastric adenocarcinoma
  • acute pyelonephritis
  • chest pain
  • dyspepsia
  • nausea
  • diarrhea
  • vomiting
  • urinary retention
  • elevated alanine aminotransferase
  • elevated aspartate aminotransferase
  • decreased appetite
  • drowsiness
  • headache
  • sensory impairment
  • nasopharyngitis
  • upper respiratory infection
  • vaginal discharge
  • itching
  • urticaria
  • arthralgia
  • musculoskeletal pain
  • limb pain
  • muscle weakness
  • myalgia
  • osteoarthritis
  • contusion
  • pharyngodynia
  • allergic rhinitis
  • asthma
  • voice disorders
  • epistaxis
  • sleep apnea syndrome
  • atherosclerosis
  • flushing
  • peripheral coldness
  • varicose veins
  • vascular headache
  • orthostatic hypotension
  • palpitations
  • insomnia
  • fatty liver
  • gallbladder polyp
  • tinnitus
  • taste impairment
  • taste abnormalities
  • drowsiness
  • tension-type headache
  • carpal tunnel syndrome
  • diabetic neuropathy
  • unconsciousness
  • nerve compression
  • neuralgia
  • peripheral neuropathy
  • sleep disorders
  • syncope
  • tremors
  • bronchitis
  • herpes zoster
  • tonsillitis
  • herpes simplex
  • hordeolum
  • joint abscess
  • laryngitis
  • otitis media
  • pelvic inflammatory disease
  • pericoronitis
  • pneumonia
  • pulmonary tuberculosis
  • rhinitis
  • onychomycosis
  • edema
  • fever
  • foreign body sensation
  • facial swelling
  • facial pain
  • warmth
  • influenza-like syndrome
  • breast mass
  • erectile dysfunction
  • benign prostatic hyperplasia
  • breast pain
  • genital rash
  • menorrhagia
  • genital edema
  • uterine bleeding
  • vaginal bleeding
  • vulvar discomfort
  • menstrual irregularities
  • hair loss
  • dermatitis
  • dry skin
  • allergic dermatitis
  • contact dermatitis
  • diabetic foot ulcer
  • sweating disorder eczema
  • coin-shaped eczema
  • eczema
  • hyperkeratosis
  • nail pigmentation
  • skin lesions
  • cold sweat
  • flank pain
  • fibromyalgia
  • limb discomfort
  • muscle cramps
  • musculoskeletal discomfort
  • osteoporosis
  • orbital fracture
  • foot fracture
  • gastrointestinal foreign body
  • laceration
  • ligament rupture
  • limb injury
  • skin abrasion
  • tendon rupture
  • tibial fracture
  • dental injury
  • dry eye
  • eye pain
  • retinal disorders
  • vision loss
  • blepharitis
  • cataract
  • conjunctival edema
  • allergic conjunctivitis
  • conjunctivitis
  • diplopia
  • eyelid swelling
  • ocular hypertension
  • visual impairment
  • vitreous floaters
  • pharyngodynia
  • allergic rhinitis
  • asthma
  • chronic obstructive disease
  • voice disorders
  • epistaxis
  • hemoptysis
  • sputum
  • sleep apnea syndrome
  • wheezing
  • atherosclerosis
  • cerebral hemorrhage
  • flushing
  • peripheral artery occlusion
  • peripheral coldness
  • varicose veins
  • vascular headache
  • orthostatic hypotension
  • angina
  • atrial fibrillation
  • diastolic dysfunction
  • myocardial infarction
  • anxiety disorder
  • enuresis
  • depression
  • hallucinations
  • sleep disorders
  • suicide attempt
  • choledocholithiasis
  • cholangitis
  • alcoholic liver cirrhosis
  • liver cysts
  • dizziness
  • gastric adenocarcinoma
  • anal genital warts
  • gastric adenoma
  • neurofibroma
  • pituitary neoplasm of unspecified type
  • male hypogonadism
  • thyroid cyst
  • thyroid nodule
  • food allergy
  • erythrocytosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. The optimal storage temperature is between 1 degree and 30 degrees Celsius at room temperature. Proper storage will help maintain the efficacy of the medication for a longer duration and ensure safe usage.

Appearance and packaging

Appearance

Pale yellow oval-shaped extended release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.